In this context, an initial molecular docking of twenty designed sulfonyl derivatives of benzimidazole against monoamine oxidase B (MAO-B) associated with PD was conducted using AutoDock Vina.<h4>Results</h4>The results were compared with those of the conventional inhibitors, selegiline and rasagiline. The gene discussed is MAOB; the disease is Parkinson disease.